Scientific and financial solvency of the company Genetracer Biotech is guaranteed by the National Innovation Company (ENISA), giving their support and trust. Enisa Web Enisa Firms May 2016
Genetracer Biotech participates as a company committed to training students in the Scholarship Program Practices in SMEs Santander Santander CRUE CEPYME 2016. The program is designed to complement the training of students of Spanish universities approaching them the reality of the professional field expanding [...]
Source: El Diario Montañés Genetracer Biotech participated last Wednesday 6th in the Technology Days organized by El Diario. Dr. Carlos Cortijo, CEO of the company Genetracer Biotech, defended the idea of the passage of traditional biopsy to the new liquid biopsy. He said in his [...]
Genetracer Biotech participated in the 14th Neotec INNVIERTE forum last November 26 taking part in the third session of presentation of projects within the area of Life Sciences. The two main objectives of these forums are investment by contacting startups with the most relevant specialized [...]
On November 6 2015, Genetracer Biotech has participated at the "II Conference of Young Scientists of Cantabria". Dr. Carlos Cortijo, CEO at Genetracer Biotech, has participated in a Roundtable entitled "Present and Future of Research Sector at Cantabria" with the Rector of the University of Cantabria, Dr. José Carlos Gómez Sal, with the Director Manager of [...]
Publication of the report on the Genetracer Biotech's activities that was published in the Annual Report of Innovation in Spain 2015, edited by INNOVASPAIN https://lnkd.in/ekR7aFu. GENETRACER BIOTECH_Anuario Inovación
Based on experience gained in the field of oncology, Genetracer Biotech has become EQA (External Quality Assessment) Assessor Scheme for lung cancer. The objective is annual provision of EQA schemes which meet international quality standards. The overall aim is improvement in the quality of molecular (genetic) testing. [...]
On October 1, 2015, Dr. Carlos Cortijo, CEO at Genetracer Biotech, has participated as speaker, at the Ion World Tour, Thermo Fisher Scientific-sponsored. The conference entitled "Analysis of exomes and transcriptomes using Ion AmpliSeq technology" has enabled Dr. Cortijo to share their experiences with Amplisq technology to Exome and [...]
This is to certify that Genetracer Biotech has participated in 2015 (Spring) in the following European Molecular Genetics Quality Network (EMQN) external quality assessment schemes: BRCA (Full scheme) EMQN_Certificateofparticipation2015_Genetracer Biotech
Genetracer Biotech has updated its website with the aim of sharing experiences of their customers regarding services performed. We would like to thank all Genetracer Biotech customers who took time to share their experiences and highlights of working with us. Genetracer Biotech is always working on improving the quality [...]
